A Phenotype–Genotype Approach to Predicting CYP450 and P-Glycoprotein Drug Interactions With the Mixed Inhibitor/Inducer Tipranavir/RitonavirJulie B. Dumond, Angela D. M. Kashuba, Manoli Vourvahis et al.|Clinical Pharmacology & Therapeutics|2010Cited by 63
Genital Tract, Cord Blood, and Amniotic Fluid Exposures of Seven Antiretroviral Drugs during and after Pregnancy in Human Immunodeficiency Virus Type 1-Infected WomenRosa F. Yeh, Kristine B. Patterson, Naser L. Rezk et al.|Antimicrobial Agents and Chemotherapy|2009Cited by 58
The Pharmacokinetics and Viral Activity of Tenofovir in the Male Genital TractManoli Vourvahis, Angela D. M. Kashuba, Hiba L. Tappouni et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2008Cited by 48
Effect of Rifampin and Rifabutin on the Pharmacokinetics of Lersivirine and Effect of Lersivirine on the Pharmacokinetics of Rifabutin and 25-<i>O</i>-Desacetyl-Rifabutin in Healthy SubjectsManoli Vourvahis, Margaret Tawadrous, Chew-Lan Chong et al.|Antimicrobial Agents and Chemotherapy|2012Cited by 22
Effects of ketoconazole and valproic acid on the pharmacokinetics of the next generation NNRTI, lersivirine (UK‐453,061), in healthy adult subjectsGrant Langdon, Manoli Vourvahis, Chew‐Lan Chong et al.|British Journal of Clinical Pharmacology|2011Cited by 17